GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (AQSE:IMM.GB) » Definitions » Cash Receipts from Tax Refunds

ImmuPharma (AQSE:IMM.GB) Cash Receipts from Tax Refunds


View and export this data going back to 2016. Start your Free Trial

What is ImmuPharma Cash Receipts from Tax Refunds?

Cash Receipts from Tax Refunds only applicable to companies reporting Cash Flow from Operations in direct method.


ImmuPharma Business Description

Industry
Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.